K · As filed with the SEC
Kellanova cash flow statement, by fiscal year
The statement as Kellanova presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENT OF CASH FLOWS · USD millions
| USD millions | FY2024 Year ended Dec 28, 2024 | FY2023 Year ended Dec 30, 2023 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Jan 1, 2022 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net income | 1,356 | 964 | 962 | 1,495 |
| Adjustments to reconcile net income to operating cash flows | ||||
| Depreciation and amortization | 367 | 419 | 478 | 467 |
| Impairment of property | 60 | — | — | — |
| Postretirement benefit plan expense (benefit) | (11) | 53 | 240 | (392) |
| Deferred income taxes | 24 | (21) | (46) | 125 |
| Stock compensation | 89 | 95 | 96 | 68 |
| Multi-employer pension plan exit liability | — | — | — | 0 |
| Loss on Russia divestiture | 0 | 113 | — | — |
| Other | (64) | 40 | (42) | (44) |
| Postretirement benefit plan distributions | 175 | — | — | — |
| Tax payment related to divestitures | — | — | — | 0 |
| Postretirement benefit plan contributions | (55) | (42) | (23) | (20) |
| Changes in operating assets and liabilities, net of acquisitions and divestitures: | ||||
| Trade receivables | (104) | (42) | (257) | (9) |
| Inventories | 2 | 139 | (411) | (135) |
| Accounts payable | 38 | (340) | 411 | 194 |
| All other current assets and liabilities | (117) | 267 | 243 | (48) |
| Net cash provided by (used in) operating activities | 1,760 | 1,645 | 1,651 | 1,701 |
| Investing activities | ||||
| Additions to properties | (628) | (677) | (488) | (553) |
| Issuance of notes receivable | 0 | (4) | (22) | (28) |
| Repayments from notes receivable | 0 | 0 | 10 | 28 |
| Divestiture, net of cash disposed | — | — | — | 0 |
| Purchases of marketable securities | (350) | — | 0 | 0 |
| Sales of marketable securities | 209 | — | 0 | 0 |
| Settlement of net investment hedges | (7) | 68 | 37 | — |
| Investments in unconsolidated entities | — | 0 | 0 | (10) |
| Purchases of available for sale securities | 0 | (15) | (17) | (61) |
| Sales of available for sale securities | 0 | 64 | 19 | 72 |
| Other | 26 | 2 | 13 | 24 |
| Net cash provided by (used in) investing activities | (750) | (562) | (448) | (528) |
| Financing activities | ||||
| Net increase (reduction) of notes payable, with maturities less than or equal to 90 days | (27) | (356) | 337 | (27) |
| Issuances of notes payable, with maturities greater than 90 days | 27 | 35 | 28 | 73 |
| Reductions of notes payable, with maturities greater than 90 days | 0 | (25) | (35) | (63) |
| Issuances of long-term debt | 619 | 404 | 39 | 361 |
| Reductions of long-term debt | (655) | (780) | (648) | (650) |
| Debt redemption costs | — | — | 0 | 0 |
| Net issuances of common stock | 213 | 60 | 277 | 63 |
| Common stock repurchases | 0 | (170) | (300) | (240) |
| Cash dividends | (776) | (800) | (797) | (788) |
| Proceeds received from debt issued and retained by WK Kellogg Co | 0 | 663 | — | — |
| Cash retained by WK Kellogg Co at separation | 0 | (78) | — | — |
| Other | (8) | (63) | 18 | (35) |
| Net cash provided by (used in) financing activities | (607) | (1,110) | (1,081) | (1,306) |
| Effect of exchange rate changes on cash and cash equivalents | — | — | — | (16) |
| Effect of exchange rate changes on cash and cash equivalents | 17 | 2 | (109) | — |
| Increase (decrease) in cash and cash equivalents | 420 | (25) | 13 | (149) |
| Cash and cash equivalents at beginning of period | — | — | 286 | 435 |
| Cash and cash equivalents at end of period | — | — | — | 286 |
| Cash and cash equivalents at beginning of period | 274 | 299 | 286 | — |
| Cash and cash equivalents at end of period | 694 | 274 | 299 | — |
| Supplemental cash flow disclosures: | ||||
| Interest paid | 303 | 291 | 220 | 213 |
| Income taxes paid | 244 | 322 | 312 | 365 |
| Supplemental cash flow disclosures of non-cash investing activities: | ||||
| Additions to properties included in accounts payable | 142 | 138 | 209 | 162 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.
